Reference
- Pugliese N, et al. Ruxolitinib and hydroxyurea combination for the treatment of myelofibrosis. HemaSphere 2 (Suppl. 1): 625-626 abstr. PB1365, Jun 2018. Available from: URL: http://doi.org/10.1097/HS9.0000000000000060 [abstract] -Italy
Copyright information
© Springer Nature Switzerland AG 2019